<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">Another concern is the prevalence of oseltamivir-resistant strains that was observed during the 2008 to 2009 season. Oseltamivir-resistant seasonal A(H1N1) viruses possessing an NA H275Y substitution spread globally, 12.3% (142/1155) in the US (
 <xref rid="bb0125" ref-type="bibr">Dharan et al., 2009</xref>), 64% in South Africa, Oceania and SE Asia (
 <xref rid="bb0250" ref-type="bibr">Hurt et al., 2009</xref>), and 20.1% in Europe. In particular, a prevalence of 67% (184/272) was observed in Norway, with a gradual increase observed in Europe from approximately 0% in week 19 to 56% in week 40 (
 <xref rid="bb0390" ref-type="bibr">Meijer et al., 2009</xref>). Thus, once the oseltamivir-resistant virus has adapted to humans, it will become or replace an epidemic virus worldwide.
</p>
